Examining the relationship between preoperative nutritional and symptom assessment and postoperative atrial fibrillation in esophageal squamous cell carcinoma patients: a retrospective cohort study

被引:0
|
作者
Chen, Yunyun [1 ]
Ma, Yan [1 ]
Wu, Haiyan [1 ]
Wei, Xinqi [1 ]
Xu, Zhiyun [1 ]
Wang, Qingmei [1 ]
机构
[1] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Thorac Surg, Huaian 223300, Peoples R China
关键词
Esophageal squamous cell carcinoma; Atrial fibrillation; Symptom assessment; Nutritional score; ASSESSMENT SCALE; CANCER PATIENTS; GASTRIC-CANCER; IMPACT; SURGERY;
D O I
10.1186/s12893-024-02609-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
ObjectiveThe study aimed to examine the relationship between preoperative nutritional status, symptom burden, and the occurrence of postoperative atrial fibrillation in Esophageal Squamous Cell Carcinoma patients.MethodsThe study, conducted in the Department of Thoracic Surgery at the Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, applied the NRS 2002, SGA and MSAS scoring systems as measures of nutritional status and symptom occurrence in patients diagnosed with ESCC. Univariate and multivariate logistic regression analysis were performed to evaluate the association between nutritional scores, symptom scores, and postoperative complications.ResultsThe research found a significant correlation between high MSAS scores and postoperative atrial fibrillation. Patients with high symptom burden also tended to have nutritional risk or malnutrition according to the NRS2002 and SGA scores.ConclusionThere is a need for healthcare providers to pay attention to ESCC patients' physical and psychological symptoms. Close monitoring of nutritional status and timely nutritional interventions should be integrated into these patients' care plans as they have been found to be related to postoperative complications such as atrial fibrillation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Prognostic Nutritional Index as a Prognostic Indicator for the Occurrence of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
    Zou, Wenbin
    Kuang, Wan
    Cai, Chun
    Qian, Yan
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 643 - 650
  • [42] Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study
    Umeki, Yusuke
    Matsuoka, Hiroshi
    Fujita, Masahiro
    Goto, Ai
    Serizawa, Akiko
    Nakamura, Kenichi
    Akimoto, Shingo
    Nakauchi, Masaya
    Tanaka, Tsuyoshi
    Shibasaki, Susumu
    Inaba, Kazuki
    Uyama, Ichiro
    Suda, Koichi
    INTERNAL MEDICINE, 2023, 62 (03) : 319 - 325
  • [43] Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study
    Lin, Chen-Yuan
    Lien, Ming-Yu
    Chen, Chi-Ching
    Fang, Hsin-Yuan
    Lin, Yu-Sen
    Chen, Chien-Kuang
    Chen, Jian-Xun
    Lu, Ting-Yu
    Huang, Tzu-Min
    Hsieh, Te-Chun
    Sun, Shung-Shung
    Li, Chia-Chin
    Chien, Chun-Ru
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [44] Relationship between nutritional status and length of hospital stay among patients with atrial fibrillation - a result of the nutritional status heart study
    Czapla, Michal
    Uchmanowicz, Izabella
    Juarez-Vela, Raul
    Durante, Angela
    Kaluzna-Oleksy, Marta
    Lokiec, Katarzyna
    Baeza-Trinidad, Ramon
    Smereka, Jacek
    FRONTIERS IN NUTRITION, 2022, 9
  • [45] Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma: a retrospective cohort study
    Zhao, Qian
    Sun, Jinglong
    Zheng, Feng
    Fu, Chengrui
    Sun, Hongfu
    Liu, Chengxin
    Wang, Zhongtang
    Huang, Wei
    Wang, Ruozheng
    Li, Baosheng
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (06) : 3440 - 3449
  • [46] Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study
    Lai, Xiaojing
    Gu, Qing
    Zheng, Xiao
    Liu, Guan
    Feng, Wei
    Lin, Xiao
    Mao, Weimin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 89 - 95
  • [47] Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study
    Meng Wang
    Changqing Hao
    Shuanghua Xie
    Shanrui Ma
    Qing Ma
    Rongshou Zheng
    Ru Chen
    Xinqing Li
    Wenqiang Wei
    Chinese Journal of Cancer Research, 2019, 31 (02) : 357 - 365
  • [48] Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study
    Saito, Yuki
    Hamamoto, Yasuo
    Hirata, Kenro
    Yamasaki, Makoto
    Watanabe, Masaya
    Abe, Tetsuya
    Tsubosa, Yasuhiro
    Hamai, Yoichi
    Murakami, Kentaro
    Bamba, Takeo
    Yoshii, Takako
    Tsuda, Masahiro
    Watanabe, Masayuki
    Ueno, Masaki
    Kitagawa, Yuko
    BMC CANCER, 2023, 23 (01)
  • [49] Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma
    Eeva Salminen
    World Journal of Gastroenterology, 2010, 16 (47) : 5975 - 5981
  • [50] Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study
    Feng, Ji-Feng
    Sheng, Chen
    Zhao, Qiang
    Chen, Pengcheng
    PEERJ, 2019, 7